|
1
|
Hakomori S: Glycosylation defining cancer
malignancy: new wine in an old bottle. Proc Natl Acad Sci USA.
99:10231–10233. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Narimatsu H: Human glycogene cloning:
focus on beta 3-glycosyltransferase and beta 4-glycosyltransferase
families. Curr Opin Struct Biol. 16:567–575. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ishida H, Togayachi A, Sakai T, et al: A
novel β1,3-N-acetylglucosaminyltransferase (β3Gn-T8), which
synthesizes poly-N-acetyllactosamine, is dramatically
upregulated in colon cancer. FEBS Lett. 579:71–78. 2005.
|
|
4
|
Mitsui Y, Yamada K, Hara S, Kinoshita M,
Hayakawa T and Kakehi K: Comparative studies on glycoproteins
expressing polylactosamine-type N-glycans in cancer cells. J Pharm
Biomed Anal. 70:718–726. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zamze S, Harvey DJ, Chen YJ, Guile GR,
Dwek RA and Wing DR: Sialylated N-glycans in adult rat brain tissue
- a widespread distribution of disialylated antennae in complex and
hybrid structures. Eur J Biochem. 258:243–270. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nishihara S, Iwasaki H, Kaneko M, Tawada
A, Ito M and Narimatsu H: α1,3-fucosyltransferase 9 (FUT9; Fuc-TIX)
preferentially fucosylates the distal GlcNAc residue of
polylactosamine chain while the other four α1,3FUT members
preferentially fucosylate the inner GlcNAc residue. FEBS Lett.
462:289–294. 1999.
|
|
7
|
Dennis JW, Granovsky M and Warren CE:
Glycoprotein glycosylation and cancer progression. Biochim Biophys
Acta. 1473:21–34. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamamoto S, Oka S, Inoue M, et al: Mice
deficient in nervous system-specific carbohydrate epitope HNK-1
exhibit impaired synaptic plasticity and spatial learning. J Biol
Chem. 277:27227–27231. 2002. View Article : Google Scholar
|
|
9
|
Shen L, Liu Z, Tu Y, Xu L, Sun X and Wu S:
Regulation of MMP-2 expression and activity by
β-1,3-N-acetylglucosaminyltransferase-8 in AGS gastric cancer
cells. Mol Biol Rep. 38:1541–1550. 2011.
|
|
10
|
Gabison EE, Hoang-Xuan T, Mauviel A and
Menashi S: EMMPRIN/CD147, an MMP modulator in cancer, development
and tissue repair. Biochimie. 87:361–368. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang W, Chang SB and Hemler ME: Links
between CD147 function, glycosylation, and caveolin-1. Mol Biol
Cell. 15:4043–4050. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Caudroy S, Polette M, Nawrocki-Raby B, et
al: EMMPRIN- mediated MMP regulation in tumor and endothelial
cells. Clin Exp Metastasis. 19:697–702. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Contessa JN, Bhojani MS, Freeze HH,
Rehemtulla A and Lawrence TS: Inhibition of N-linked glycosylation
disrupts receptor tyrosine kinase signaling in tumor cells. Cancer
Res. 68:3803–3809. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Venkatesan B, Valente AJ, Prabhu SD,
Shanmugam P, Delafontaine P and Chandrasekar B: EMMPRIN activates
multiple transcription factors in cardiomyocytes, and induces
interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB
andMKK7/JNK/AP-1 signaling. J Mol Cell Cardiol. 49:655–663. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamamoto H, Swoger J, Greene S, et al:
β1,6-N-acetylglucosamine-bearing N-glycans in human
gliomas: implications for a role in regulating invasivity. Cancer
Res. 60:134–142. 2000.
|
|
16
|
Agrawal SM and Yong VW: The many faces of
EMMPRIN-roles in neuroinflammation. Biochim Biophys Acta.
1812:213–219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan J, Wang S, Yu S, He J, Zheng W and
Zhang J: N-acetylglucosaminyltransferase IVa regulates
metastatic potential of mouse hepatocarcinoma cells through
glycosylation of CD147. Glycoconj J. 29:323–334. 2012. View Article : Google Scholar
|
|
18
|
Yu XL, Jiang JL, Li L, Feng Q, Xu J and
Chen ZN: The glycosylation characteristic of hepatoma-associated
antigen HAb18G/CD147 in human hepatoma cells. Int J Biochem Cell
Biol. 38:1939–1945. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun J and Hemler ME: Regulation of MMP-1
and MMP-2 production through CD147/extracellular matrix
metalloproteinase inducer interactions. Cancer Res. 61:2276–2281.
2001.PubMed/NCBI
|
|
20
|
Huang W, Luo WJ, Zhu P, et al: Modulation
of CD147-induced matrix metalloproteinase activity: role of CD147
N-glycosylation. Biochem J. 449:437–448. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Seko A and Yamashita K: Activation of
β1,3-N-acetylglucosaminyltransferase-2 (β3Gn-T2) by β3Gn-T8:
Possible involvement of β3Gn-T8 in increasing
poly-N-acetyllactosamine chains in differentiated HL-60 cells. J
Biol Chem. 283:33094–33100. 2008.
|
|
22
|
Huang C, Zhou J, Wu S, Shan Y, Teng S and
Yu L: Cloning and tissue distribution of the human B3GALT7 gene, a
member of the beta1,3-glycosyltransferase family. Glycoconj J.
21:267–273. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saitoh O, Wang WC, Lotan R and Fukuda M:
Differential glycosylation and cell surface expression of lysosomal
membrane glycoproteins in sublines of a human colon cancer
exhibiting distinct metastatic potentials. J Biol Chem.
267:5700–5711. 1992.
|
|
24
|
Taniguchi N, Miyoshi E, Ko JH, Ikeda Y and
Ihara Y: Implication of N-acetylglucosaminyltransferases III and V
in cancer: gene regulation and signaling mechanism. Biochim Biophys
Acta. 1455:287–300. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Togayachi A, Akashima T, Ookubo R, et al:
Molecular cloning and characterization of
UDP-GlcNAc:lactosylceramide beta
1,3-N-acetylglucosaminyltransferase (beta 3Gn-T5), an essential
enzyme for the expression of HNK-1 and Lewis X epitopes on
glycolipids. J Biol Chem. 276:22032–22040. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shiraishi N, Natsume A, Togayachi A, et
al: Identification and characterization of three novel β
1,3-N-acetylglucosaminyltransferases structurally related to
the β1,3-galactosyltransferase family. J Biol Chem. 276:3498–3507.
2001.
|
|
27
|
Dennis JW, Laferte S and Vanderelst I:
Asparagine-linked oligosaccharides in malignant tumour growth.
Biochem Soc Trans. 17:29–31. 1989.PubMed/NCBI
|
|
28
|
Dennis JW and Laferte S: Oncodevelopmental
expression of -GlcNAc β1-6Man α 1-6Man β1-branched
asparagine-linked oligosaccharides in murine tissues and human
breast carcinomas. Cancer Res. 49:945–950. 1989.
|
|
29
|
Seberger PJ and Chaney WG: Control of
metastasis by Asn-linked, β-6-branched oligosaccharides in mouse
mammary cancer cells. Glycobiology. 9:235–241. 1999.
|
|
30
|
Granovsky M, Fata J, Pawling J, Muller WJ,
Khokha R and Dennis JW: Suppression of tumor growth and metastasis
in Mgat5-deficient mice. Nat Med. 6:306–312. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Del Grosso F, De Mariano M, Passoni L,
Luksch R, Tonini GP and Longo L: Inhibition of N-linked
glycosylation impairs ALK phosphorylation and disrupts pro-survival
signaling in neuroblastoma cell lines. BMC Cancer.
11:5252011.PubMed/NCBI
|
